Last Trading Session: As EquityPandit predicted that market would open in positive region and also it would remain positive for the whole day and same happened. Finally market managed to end with sharp positive trends. Market exactly saw a strong resistance at equitypandit predicted resistance levels of 20650 for Sensex.

Today: Market likely to see positive gap up opening. Some profit booking can be seen at these levels. Overall market is positive. Since EquityPandit resistance and support levels always meet accuracy, Traders should take care of all the support and resistance levels as not taking care of support levels may lead to losses. Investor can remain invested.  

BSE Sensex: (20561) The support for the Sensex is 20400 and the resistance to the up move is at 20650-20805.

NSE Nifty: (6158) The support for the Nifty is at 6100 and the resistance to the up move is at 6185-6205.

GAIN HUGE PROFITS WITH EP-INVESTOR

 

All EP-Investor calls have given more than 25% profits within small time frame. Few calls like concurrent Infra, unimin, Hanung toys have even given more than 300% profits in 2 months. Don’t miss the opportunity to subscribe to EP-Investor Package. All the calls have given very good profits even when market went down. (Detailed performance sheet can be viewed at www.equitypandit.in )

EP-Investor is flagship product of EquityPandit.

Note: Stocks to trade for F&O and cash intraday and when to exit those stocks would be sent to paid subscribers live during the market hours through SMS.

EP-Value : New Package Launched.

EquityPandit Launched its new package called “EP-Value”. In this package midcap recommendation would be given every month for long term which has ability to convert into large cap in future.  Each and every recommendation would give atleast 100-200% profits in next 1-2 years.

PRICE: Rs.7000 (Yearly Subscription)

Promotional offer: Rs.1599 (Yearly Subscription), not even Rs.134 monthly. So hurry up and subscribe today as this offer is limited and based on first come and first serve.